TrialBMC psychiatry2024

Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trial.

Atefeh Zandifar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.